Bachmann F, Hartl W
Dtsch Med Wochenschr. 1977 Dec 2;102(48):1772-5. doi: 10.1055/s-0028-1105577.
MK-231 (Sulindac), 200-400 mg daily, was given to 25 patients with rheumatoid arthritis. The therapeutic response was good and there were no side effects at all. The drug should be used more frequently than heretofore in the drug treatment of symptoms of rheumatoid arthritis.
将25例类风湿性关节炎患者每日服用200 - 400毫克的MK - 231(舒林酸)。治疗反应良好,且完全没有副作用。在类风湿性关节炎症状的药物治疗中,该药物应比以往更频繁地使用。